Total planned funding: $738,576,515
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $158,563,375 |
| Uganda | $109,698,557 |
| Kenya | $85,116,291 |
| Zambia | $66,014,624 |
| Mozambique | $53,982,427 |
| South Africa | $45,655,706 |
| Côte d'Ivoire | $40,263,892 |
| Ethiopia | $37,512,102 |
| Tanzania | $35,006,915 |
| Rwanda | $26,902,583 |
| Vietnam | $22,709,620 |
| Zimbabwe | $20,514,348 |
| Botswana | $11,987,045 |
| Haiti | $10,713,812 |
| Namibia | $6,997,291 |
| Guyana | $3,337,325 |
| Democratic Republic of the Congo | $1,483,576 |
| Burundi | $1,208,202 |
| Eswatini | $309,961 |
| Lesotho | $300,000 |
| Malawi | $163,542 |
| China | $100,000 |
| Angola | $34,000 |
| Cambodia | $1,321 |
Organizational Types
| Private Contractor | $438,338,850 |
| NGO | $105,514,024 |
| FBO | $71,487,415 |
| Unknown | $49,110,172 |
| University | $46,296,952 |
| Host Country Government Agency | $20,640,553 |
| Implementing Agency | $3,400,000 |
| Own Agency | $2,468,549 |
| Parastatal | $1,020,000 |
| Other USG Agency | $300,000 |
Program Areas
| Treatment | $738,576,515 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $738,576,515 |